Evidence map›Paper›PMID 32207036›Full record

SynthesisEndocrine2020

Effect of subclinical hyperthyroidism on osteoporosis: A meta-analysis of cohort studies.

Ningning Xu, Yaxian Wang, Yuying Xu, Lishan Li, Jiaqi Chen, Xudong Mai, Jie Xu, Zhen Zhang, Rui Yang, Jia Sun and 2 more

Abstract readMeta-AnalysisReview
PubMed Publisher
In one paragraph

Synthesis in Endocrine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Effects of vitamin DEndocrine · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ningning XuDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Yaxian WangDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Yuying XuDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Lishan LiDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Jiaqi ChenDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Xudong MaiDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Jie XuDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhen ZhangDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Rui YangDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Jia SunDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Hong ChenDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. chenhong123@smu.edu.cn.
Rongping ChenDepartment of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. 62782333@163.com.
Southern Medical University · CNZhujiang Hospital · CN

Funding

National Natural Science Foundation of China 81770804Science and Technology Planning Project of Guangdong Province (CN) 2014A020212177
6 · The paper itself

Abstract

objectiveThe effect of subclinical hyperthyroidism (SH) on bone mineral density (BMD) remains unclear, as do the linking mechanisms. This review aims to investigate the relationship between SH and bone loss in terms of the gender-dependent effects of SH on BMD.

methodsThe PUBMED, EMBASE, OVID, MEDLINE, SINOMED and COCHRANE LIBRARY databases (inception to August 12, 2019) were searched for cohort studies investigating the effects of SH on BMD. Eligible studies were subjected to qualitative and quantitative analysis using a random-effects model meta-analysis with the Cochrane systematic evaluation method.

resultsTwelve cohort studies involving 275,086 participants who were followed for 3 months to 13 years were included based on predefined inclusion and exclusion criteria. The results indicated that SH did not affect lumbar spine BMD in females or males. However, a significant reduction in femoral neck BMD was observed in females, but not in males. Further, there was a significant increase in hip fractures events in both females and males with SH.

conclusionsThe present findings indicate that SH is significantly associated with hip fracture risk, and therefore, it is important to assess the risk of fractures in patients with SH. Future studies should focus on methods for accurately determining this risk in patients with SH and providing them with timely and efficient diagnosis and treatment.

Indexed as

Bone Density Conservation AgentsHyperthyroidismOsteoporosisBone DensityCohort StudiesFemaleHumansMaleBone Density Conservation AgentsBone healthFracture riskHyperthyroidismMeta-analysisOsteoporosisReview

Identifiers

PMID32207036
OpenAlexW3012896412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.